LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the 4th Annual Collins Stewart Growth Conference on Tuesday, July 8, 2008 at 3:00 p.m. (ET) at Mandarin Oriental Hotel in New York.
